TNF and primary central nervous system lymphoma: The results of studies performed with NGR-TNF in animal models of solid tumors and in PCNSL patients suggest that coupling TNF with the CNGRCG peptide (NGR) is a valuable strategy for delivering an amount of cytokine to tumor blood vasculature sufficient to alter the biological barriers that limit drug penetration in cancer lesions, including the BBTB.